QURE News

ROSEN, A LEADING LAW FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE

Pomerantz LLP Advises Investors of Class Action Involving uniQure N.V. – QURE

QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages uniQure N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - QURE

Pomerantz LLP Advises Shareholders of Class Action Against uniQure N.V. – QURE

Pomerantz LLP Advises Investors of Class Action Filing Involving uniQure N.V. – QURE

QURE SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE

Pomerantz LLP Advises of Securities Class Action Involving uniQure N.V. – QURE